Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Tc1 mouse model of Down syndrome (DS) is functionally trisomic for ∼120 human chromosome 21 (HSA21) classical protein-coding genes. Tc1 mice display features relevant to the DS phenotype, including abnormalities in learning and memory and synaptic plasticity. To determine the molecular basis for the phenotypic features, the levels of 90 phosphorylation-specific and phosphorylation-independent proteins were measured by Reverse Phase Protein Arrays in hippocampus and cortex, and 64 in cerebellum, of Tc1 mice and littermate controls. Abnormal levels of proteins involved in MAP kinase, mTOR, GSK3B and neuregulin signaling were identified in trisomic mice. In addition, altered correlations among the levels of N-methyl-D-aspartate (NMDA) receptor subunits and the HSA21 proteins amyloid beta (A4) precursor protein (APP) and TIAM1, and between immediate early gene (IEG) proteins and the HSA21 protein superoxide dismutase-1 (SOD1) were found in the hippocampus of Tc1 mice, suggesting altered stoichiometry among these sets of functionally interacting proteins. Protein abnormalities in Tc1 mice were compared with the results of a similar analysis of Ts65Dn mice, a DS mouse model that is trisomic for orthologs of 50 genes trisomic in the Tc1 plus an additional 38 HSA21 orthologs. While there are similarities, abnormalities unique to the Tc1 include increased levels of the S100B calcium-binding protein, mTOR proteins RAPTOR and P70S6, the AMP-kinase catalytic subunit AMPKA, the IEG proteins FBJ murine osteosarcoma viral oncogene homolog (CFOS) and activity-regulated cytoskeleton-associated protein (ARC), and the neuregulin 1 receptor ERBB4. These data identify novel perturbations, relevant to neurological function and to some seen in Alzheimer's disease, that may occur in the DS brain, potentially contributing to phenotypic features and influencing drug responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566 · cited 1×
“Furthermore, discrepancies between mRNA and protein levels are increasingly being documented (31), and have been reported specifically in aneuploidy (32).”
BackgroundNeuregulin 1 in neural development, synaptic plasticity and schizophrenia
Mei, L., & Xiong, W.-C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2392 · Cited by 1,030 · cited 3×
“However, levels of ERBB4, the major receptor in brain for neuregulin 1 (NRG1)(22), were elevated in both the cortex and hippocampus.”
BackgroundInfluentialAn Aneuploid Mouse Strain Carrying Human Chromosome 21 with down Syndrome Phenotypes.
O'Doherty, A., Ruf, S., Mulligan, C., Hildreth, V., Errington, M. L., Cooke, S., Sesay, A., Modino, S., Vanes, L., Hernandez, D., et al. (2005) · Science · doi:10.1126/science.1114535 · Cited by 434
Self-citationTolias, K. F., Bikoff, J. B., Burette, A., Paradis, S., Harrar, D., Tavazoie, S., Weinberg, R. J., & Greenberg, M. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.024 · Cited by 365 · cited 1×
“Both TIAM1 and APP interact directly with NMDA receptor subunits, TIAM1, in regulation of dendritic spine morphology (27,28) and APP, to facilitate cell surface expression of the NMDA receptor (29).”
BackgroundDown syndrome: Cognitive phenotype
Silverman, W. (2007) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20156 · Cited by 324
Chen, L., Xu, B., Liu, L., Luo, Y., Yin, J., Zhou, H., Chen, W., Shen, T., Han, X., & Huang, S. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.36 · Cited by 236 · cited 10×
“(ii) The AMP-activated Protein Kinase, AMPK, is a master regulator of cellular energy homeostasis.”
BackgroundInfluentialDuchon, A., Raveau, M., Chevalier, C., Nalesso, V., Sharp, A. J., & Herault, Y. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9356-0 · Cited by 224 · cited 1×
“This has recently been shown to include 50 genes (49,50), including paralogs of several HSA21 protein-coding genes, TIAM2, SYNJ2, TCP10A, TCP10B and PDE10a (see Supplementary Material, Table S6B for the complete list).”
BackgroundDown syndrome and dementia: A randomized, controlled trial of antioxidant supplementation
Lott, I. T., Doran, E., Nguyen, V. Q., Tournay, A., Head, E., & Gillen, D. L. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34114 · Cited by 136
Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions
Sturgeon, X., & Gardiner, K. J. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9321-y · Cited by 117
Self-citationLoss of correlations among proteins in brains of the Ts65Dn mouse model of down syndrome
Ahmed, M. M., Sturgeon, X., Ellison, M., Davisson, M. T., & Gardiner, K. J. (2012) · Journal of Proteome Research · doi:10.1021/pr2011582 · Cited by 39 · cited 10×
“Procedures for array screening have been described previously (13).”
BackgroundMethodSelf-citation
Research works printed but not linked: 47
- 2006, MMWR. Morbidity and mortality weekly report, 54, 6
- Irving, 2008, European journal of human genetics : EJHG, 16, 1336, 10.1038/ejhg.2008.122 · DOI
- Chapman, 2000, Mental retardation and developmental disabilities research reviews, 6, 84, 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.0.CO;2-P · DOI · Paper page
- Edgin, 2010, 2, 149, 10.1007/s11689-010-9054-3 · DOI · Paper page
- Benavides-Piccione, 2004, Progress in neurobiology, 74, 111, 10.1016/j.pneurobio.2004.08.001 · DOI
- Lott, 2010, Lancet. Neurology, 9, 623, 10.1016/S1474-4422(10)70112-5 · DOI · Paper page
- 2006, J MED GENET C SEMIN MED GENET, 142C, 158, 10.1002/ajmg.c.30097 · DOI · Paper page
- 2011, MAM GENOME, 22, 61
- Kuhn, 2012, 7, e31433, 10.1371/journal.pone.0031433 · DOI
- Morice, 2008, Learning & Memory, 15, 492, 10.1101/lm.969608 · DOI · Paper page
- Qi, 2001, Cell Growth & Differentiation, 12, 603
- Sheppard, 2012, Neurobiology of aging, 33, 828.e31, 10.1016/j.neurobiolaging.2011.06.025 · DOI · Paper page
- Allison, 2011, Neuroscience research, 70, 155, 10.1016/j.neures.2011.02.009 · DOI
- Wong, 2012, 7, e36023, 10.1371/journal.pone.0036023 · DOI
- Harashima, 2006, The Journal of comparative neurology, 494, 815, 10.1002/cne.20844 · DOI · Paper page
- 2011, 2011, 153218
- Troca-Marin, 2011, Journal of Neuroscience, 31, 9445, 10.1523/JNEUROSCI.0011-11.2011 · DOI · Paper page
- 2006, Molecular Biology of the Cell, 17, 1273, 10.1091/mbc.E05-07-0700 · DOI · Paper page
- Siddiqui, 2008, Genes, brain, and behavior, 7, 810, 10.1111/j.1601-183X.2008.00428.x · DOI · Paper page
- Nguyen, 2011, Journal of neurogenetics, 25, 40, 10.3109/01677063.2011.558606 · DOI
- 2009, Neuron, 61, 160, 10.1016/j.neuron.2009.01.001 · DOI · Paper page
- Ehler, 1997, Molecular and cellular neurosciences, 9, 1, 10.1006/mcne.1997.0602 · DOI
- 2007, PNAS, 104, 7265, 10.1073/pnas.0702044104 · DOI · Paper page
- Cousins, 2009, Journal of neurochemistry, 111, 1501, 10.1111/j.1471-4159.2009.06424.x · DOI · Paper page
- Vilardell, 2011, BMC genomics [electronic resource], 12, 229, 10.1186/1471-2164-12-229 · DOI · Paper page
- Stingele, 2012, 8, 608, 10.1038/msb.2012.40 · DOI · Paper page
- 2009, Molecular & Cellular Proteomics, 8, 585, 10.1074/mcp.M800256-MCP200 · DOI
- Cohen, 2001, Nature reviews. Molecular cell biology, 2, 769, 10.1038/35096075 · DOI · Paper page
- Sturgeon, 2012, Progress in brain research, 197, 73, 10.1016/B978-0-444-54299-1.00005-4 · DOI
- 2012, Gene, 512, 219
- Vullhorst, 2009, Journal of Neuroscience, 29, 12255, 10.1523/JNEUROSCI.2454-09.2009 · DOI · Paper page
- 2010, PNAS, 107, 21818, 10.1073/pnas.1010669107 · DOI · Paper page
- Kaphzan, 2012, Biological psychiatry, 72, 182, 10.1016/j.biopsych.2012.01.021 · DOI · Paper page
- Woo, 2011, 44, 116, 10.5115/acb.2011.44.2.116 · DOI
- Cai, 2012, Neuromolecular medicine, 14, 1, 10.1007/s12017-012-8173-2 · DOI · Paper page
- Potter, 2010, 5, e8996, 10.1371/journal.pone.0008996 · DOI · Paper page
- 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 7, 241
- Chaum, 2011, Neurochemical research, 36, 574, 10.1007/s11064-010-0370-5 · DOI
- Kaur, 2008, Indian journal of experimental biology, 46, 562
- Sun, 2009, Free radical biology & medicine, 47, 1753, 10.1016/j.freeradbiomed.2009.09.021 · DOI
- Tlili, 2012, Molecular neurobiology, 46, 297, 10.1007/s12035-012-8284-7 · DOI
- 2011, Genome (Ottawa. Print), 22, 685
- Chen, 2012, International journal of cancer. Journal international du cancer, 130, 1302, 10.1002/ijc.26117 · DOI
- Hanney, 2012, Lancet, 379, 528, 10.1016/S0140-6736(11)61676-0 · DOI · Paper page
- 2012, TRANSL PSYCHIATRY, 2, 141e, 10.1038/tp.2012.66 · DOI · Paper page
- Ahmed, 2011, Journal of neuroscience methods, 196, 99, 10.1016/j.jneumeth.2011.01.004 · DOI
- Svensson, 2009, Journal of proteome research, 8, 974, 10.1021/pr8006446 · DOI · Paper page
Cited by
Trisomy 21 consistently activates the interferon response
Sullivan, K. D., Lewis, H. C., Hill, A. A., Pandey, A., Jackson, L. P., Cabral, J. M., Smith, K. P., Liggett, L. A., Gomez, E. B., Galbraith, M. D., et al. (2016) · eLife · doi:10.7554/elife.16220 · Cited by 362
“This could be consistent with previous reports showing hyperactivation of mTOR signaling in the brains of individuals with DS and mouse models of trisomy 21 and consequent impairments in autophagy (Ahmed et al., 2013; Perluigi et al., 2015; Troca-Marı́n et al., 2014; Iyer et al., 2014).”
ResultDown syndrome and Alzheimer's disease: common pathways, common goals
Hartley, D., Blumenthal, T., Carrillo, M., DiPaolo, G., Esralew, L., Gardiner, K., Granholm, A.-C., Iqbal, K., Krams, M., Lemere, C., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.007 · Cited by 290
“[56] Ahmed MM, Dhanasekaran AR, Tong S, Wiseman FK, Fisher EM,”
BackgroundSelf-citationBrain insulin resistance triggers early onset Alzheimer disease in Down syndrome
Tramutola, A., Lanzillotta, C., Di Domenico, F., Head, E., Butterfield, D. A., Perluigi, M., & Barone, E. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104772 · Cited by 73
Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome
D. Hamlett, E., A. Boger, H., Ledreux, A., M. Kelley, C., J. Mufson, E., F. Falangola, M., N. Guilfoyle, D., A. Nixon, R., Patterson, D., Duval, N., et al. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150921095505 · Cited by 46
Block, A., Ahmed, M. M., Dhanasekaran, A. R., Tong, S., & Gardiner, K. J. (2015) · Biology of Sex Differences · doi:10.1186/s13293-015-0043-9 · Cited by 43
“tion and review of data quality and reproducibility were as described previously [48, 49, 50].”
BackgroundMethodSelf-citation
Metadata
- Authors
- Ahmed, M. M., Dhanasekaran, A. R., Tong, S., Wiseman, F. K., Fisher, E. M. C., Tybulewicz, V. L. J., & Gardiner, K. J.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-24
- Volume
- 22
- Issue
- 9
- Pages
- 1709-1724
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2131055269
- Cited by
- 42
- References
- 10
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.